Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-052532
Filing Date
2022-10-04
Accepted
2022-10-04 19:22:53
Documents
2
Period of Report
2022-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5795
2 EX-24 DOCUMENT attachment1.htm EX-24 2177
  Complete submission text file 0001209191-22-052532.txt   9446
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALECTOR, INC 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Kenkare-Mitra Sara (Reporting) CIK: 0001895592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 221293893